in the past decade in vitro tests have been developed that represent a
range of anatomic structure from perfused whole organs to subcellular
fractions. To assess the use of in vitro tests for toxicity testing,
we describe and evaluate the current status of organotypic cultures fo
r the major target organs of toxic agents. This includes liver, kidney
, neural tissue, the hematopoietic system, the immune system, reproduc
tive organs, and the endocrine system. The second part of this report
reviews the application of in vitro culture systems to organ specific
toxicity and evaluates the application of these systems both in indust
ry for safety assessment and in government for regulatory purposes. Me
mbers of the working group (WG) felt that access to high-quality human
material is essential for better use of in vitro organ and tissue cul
tures in the risk assessment process. Therefore, research should focus
on improving culture techniques that will allow better preservation o
f human material. The WG felt that it is also important to develop and
make available relevant reference compounds for toxicity assessment i
n each organ system, to organize and make available via the internet c
omplete in vivo toxicity data, including human data, containing dose,
end points, and toxicokinetics. The WG also recommended that research
should be supported to identify and to validate biological end points
for target organ toxicity to be used in alternative toxicity testing s
trategies.